←
Mark Hirsch5,170 posts
Mark Hirsch avatar

Mark Hirsch

@MarkAHirsch

Professor, Physical Medicine and Rehabilitation, Wake Forest University School of Medicine, Carolinas Rehabilitation, Charlotte

◷ Joined December 2015▧ 188 Photos and videos
Michael Okun avatar
⟳ Mark Hirsch retweeted
Michael Okun@MichaelOkun·Nov 16

Our second session this morning at the 2nd Annual Parkinson’s Disease Prevention Think Tank, co-sponsored by the Parkinson’s Foundation and the University of Florida Norman Fixel Institute for Neurological Diseases, focused on Paraquat and the Policy Landscape. What resonated with me most was the urgent need to bridge the gap between scientific evidence, environmental exposure, and meaningful policy action. Andi Lipstein Fristedt highlighted the growing momentum to restrict environmental toxins linked to Parkinson’s disease and emphasized that progress will require strong research, committed policymakers, and bipartisan champions willing to translate evidence into action. Trevor Archer, PhD, from the National Institute of Environmental Health Sciences (NIEHS), reminded us that prevention requires a broader scientific understanding of environmental exposures, including pesticides such as paraquat, rotenone, and chlorpyrifos, as well as air pollution, metals, and industrial chemicals. NIEHS has an important opportunity to contribute its expertise in exposomics, neurotoxicity, and population studies to the National Plan to End Parkinson’s Disease. Ari Bernstein, MD, MPH, discussed the unique capabilities of the CDC's National Center for Environmental Health and Agency for Toxic Substances and Disease Registry to measure environmental exposures in Americans, monitor vulnerable communities, and leverage experience with disease registries and biobanks, including those developed for ALS. Finally, Jim Jones, discussing the EPA and environmental exposure data, raised perhaps the most provocative issue of the session: the distinction between association and causation. He explained that the EPA has historically required evidence of causality rather than epidemiological association to justify chemical regulation, and that the agency has viewed the relationship between paraquat and Parkinson’s disease as an association without established causality. What resonated with me is that we must confront a fundamental question: How much evidence should society require before taking action to prevent a potentially devastating, irreversible brain disease? Scientific rigor is essential, but waiting for absolute certainty may mean missing opportunities to protect future generations. We need better exposure measurements, stronger science, thoughtful regulation, and policymakers willing to act on the best available evidence. Primary prevention means having the courage to intervene before people develop Parkinson’s disease, rather than waiting until the damage has already been done.

Post attachment
Michael Okun avatar
⟳ Mark Hirsch retweeted
Michael Okun@MichaelOkun·Nov 17

Agent Orange and Parkinson's disease: The war ended, but the toxic exposures did not. A landmark study of 4.4 million veterans reveals a troubling connection. Agent Orange was a toxic herbicide mixture sprayed extensively during the Vietnam War. It contained 2,4-D, 2,4,5-T and contamination by dioxin, a highly toxic chemical. Gregory Scott and colleagues describe in a new landmark paper in JAMA Neurology how exposure to Agent Orange was associated w/ a substantially increased risk of Parkinson's disease and related brain disorders. Samuel Goldman, Ray Dorsey and I authored an accompanying editorial highlighting why these findings matter not only for veterans, but also for the millions of folks potentially exposed to pesticides today. Key points: - Among more than 4.4 million US veterans, Agent Orange exposure was associated w/ a 44% increased risk of Parkinson's disease, even after accounting for important factors including age, traumatic brain injury and other medical conditions. - Veterans who directly handled or sprayed Agent Orange had a 99% increased risk of Parkinson's disease, suggesting that greater exposure may carry greater risk. - The association extended beyond Parkinson's disease to REM sleep behavior disorder (78% increased risk) and dementia w/ Lewy bodies (66% increased risk), suggesting that toxic exposures may contribute to a broader spectrum of neurodegenerative diseases. My take: This is a landmark study and an important moment for Parkinson's disease prevention. For decades, veterans have asked whether their exposure to Agent Orange contributed to their Parkinson's disease. We now have compelling epidemiological evidence supporting this association. Although observational studies cannot establish causation, the size of this investigation, the strength of the associations and the apparent exposure-response relationship are difficult to ignore. What particularly concerns me is that the story does not end in Vietnam. In our accompanying editorial, Goldman, Dorsey and I emphasize that 2,4-D, one of the major components of Agent Orange, remains widely used today on farms, golf courses, lawns and other public spaces. More than 20 million kilograms of 2,4-D are applied annually for agricultural purposes in the US, approximately 4 times the amount of paraquat. We should not assume that today's exposures carry the same risks as the wartime mixture, but we urgently need to understand the long-term neurological consequences of these chemicals. Here are 5 points that resonated w/ me: 1- Our veterans deserve answers. This study provides powerful evidence supporting the connection between Agent Orange exposure and Parkinson's disease and reinforces the importance of recognizing and caring for affected veterans. 2- Exposure matters. The nearly doubled risk among veterans who directly handled Agent Orange raises serious concerns about cumulative exposure and suggests that reducing toxic exposures could be an important prevention strategy. 3- Parkinson's disease may not be the only consequence. The associations w/ REM sleep behavior disorder and dementia w/ Lewy bodies suggest that environmental toxins may influence multiple diseases involving abnormal alpha-synuclein accumulation in the brain. 4- The exposure story extends beyond the battlefield. The continued widespread use of 2,4-D should prompt serious scientific investigation, stronger exposure monitoring and thoughtful regulatory scrutiny. We should not wait decades to understand the consequences of chemicals used in our communities. 5- It is time to move Parkinson's disease prevention from discussion to action. We must invest in identifying environmental risk factors, reducing preventable exposures and protecting future generations. We cannot treat our way out of an epidemic if we ignore what may be helping to fuel it. The war ended more than 50 years ago, but its neurological consequences continue. The question now is whether we will learn from history and act before another generation pays the price. doi.org/10.1001/jamaneurol.2… doi.org/10.1001/jamaneurol.2…

Post attachment
MIT School of Engineering avatar
⟳ Mark Hirsch retweeted
MIT School of Engineering@MITEngineering·Nov 15

MIT researchers have generated a new atlas of the neurons found within the striatum, a region of the brain that is critical for many cognitive and motor functions. The results could help scientists develop new drugs to combat addiction and schizophrenia. news.mit.edu/2026/brains-str…

News from Science avatar
⟳ Mark Hirsch retweeted
News from Science@NewsfromScience·Nov 15

Tinnitus—a constant ringing or buzzing in the ears that affects about 15% of people—is difficult to understand and even harder to treat. In 2020, scientists found that shocking the tongue—combined with a carefully designed sound program—can reduce symptoms of the disorder, not just while patients are being treated, but up to 1 year later. Learn more: scim.ag/48aGMQX #ScienceMagArchives

Post attachment
Weigang Cui avatar
⟳ Mark Hirsch retweeted
Weigang Cui@WeigangCui94·Nov 6

Methodological debates move the field forward. Recent debates on lesion network mapping (LNM) motivated us to develop robust LNM (rLNM), combining spatial null models and selective specificity to distinguish symptom effects from shared background. biorxiv.org/content/10.64898…

Post attachment
nature avatar
⟳ Mark Hirsch retweeted
nature@Nature·Nov 13

Researchers have published the world's most detailed atlas of basal ganglia, comprising 25.5 million brain cells go.nature.com/4C1XQpP

Michael Okun avatar
⟳ Mark Hirsch retweeted
Michael Okun@MichaelOkun·Nov 12

Can AI Diagnose Parkinson’s Disease? My Interview with Reid Hoffman’s AI Digital Twin. Will earlier be better and and give doctors more time to care for their patients? At the Masters of Scale Summit in Silicon Valley, I had a fascinating conversation with an AI digital twin of Reid Hoffman about the future of artificial intelligence in healthcare and how emerging technologies could transform the diagnosis and treatment of neurological diseases. - One of the most exciting developments we discussed was Neuropacs, an AI-powered technology that analyzes brain MRI scans to help distinguish Parkinson’s disease from conditions that can look remarkably similar, including progressive supranuclear palsy (PSP) and multiple system atrophy (MSA). - Why does this matter? Getting the diagnosis right, and getting it right early, can change how we counsel patients, select treatments, plan care, and approach clinical trials. Parkinson’s disease, PSP, and MSA may share symptoms, but they are different diseases with different prognoses and treatment considerations. - What excites me most about AI is not the possibility of replacing physicians. It is the opportunity to make physicians better. If AI can help us interpret complex diagnostic information more efficiently, we can spend less time sorting through data and more time sitting with patients and families, explaining what the diagnosis means, answering questions, and developing a personalized plan. - The future of AI in medicine should not be about replacing the human connection. It should be about strengthening it. - Join me for this amazing conversation (with Reid's digital twin) about Parkinson’s disease, brain MRI, artificial intelligence, and the future of neurological care. youtube.com/shorts/3EwGLqc_H…

1:36
么 ꜱ ᴀ ᴍ ꪜ, avatar
⟳ Mark Hirsch retweeted
么 ꜱ ᴀ ᴍ ꪜ,@___TheGOOdWitch·Nov 12

Evolutionary Professor explains why we are all Africans🤔💯

4:27
Movement Disorders Clinical Practice avatar
⟳ Mark Hirsch retweeted
Movement Disorders Clinical Practice@MDCP_Journal·Nov 12

A positive α-synuclein test is not a Parkinson's diagnosis. But it can change a life. This important paper explores the ethical challenge of prodromal PD: how do we discuss biomarkers, RBD and future disease risk without creating anxiety, stigma and loss of identity? As biomarkers improve, communication skills may become just as important as diagnostic accuracy. loom.ly/Pm3-zos

ACRM and ACRM Annual Fall Conference avatar
⟳ Mark Hirsch retweeted
ACRM and ACRM Annual Fall Conference@ACRMconference·Nov 10

Celebrating Excellence in Rehabilitation! ACRM proudly congratulates Tolu Oyesanya of Duke University School of Nursing on being named a 2026 ACRM Fellow (FACRM)! This recognition honors her professional contributions, leadership, and commitment to advancing rehabilitation research and practice. Please join us in celebrating Tolu and this well-deserved achievement! #ACRM #ACRM2026 #ACRMFellows #FACRM #RehabilitationResearch #RehabilitationMedicine

Post attachment
Eric Topol avatar
⟳ Mark Hirsch retweeted
Eric Topol@EricTopol·Nov 10

What accounts for genetic resistance to Alzheimer's disease and dementia? Many known protective gene variants are very instructive Feature @Nature nature.com/articles/d41586-0…

Michael Okun avatar
⟳ Mark Hirsch retweeted
Michael Okun@MichaelOkun·Nov 10

This fascinating editorial in JAMA Neurology by Sirwan Darweesh, Matthew Remz, and Samuel Goldman resonates with me because it challenges us to think differently about the environmental and biological factors that may influence Parkinson’s disease risk. For decades, we have known about the paradoxical association between cigarette smoking and a lower risk of Parkinson’s disease, but we have struggled to understand why. Could carbon monoxide, a gas we typically associate with poisoning and environmental danger, provide part of the explanation? In a remarkable study of more than 500,000 Chinese adults followed for approximately 12 years, higher exhaled carbon monoxide levels were associated with a 35% lower risk of developing Parkinson’s disease among never-smokers in the highest exposure group. The possibility that low concentrations of carbon monoxide may influence oxidative stress, inflammation, and neuronal survival is intriguing, but association does not establish causation. Smoking and carbon monoxide exposure remain dangerous and should never be recommended for prevention. What particularly resonates with me is the opportunity to separate potentially beneficial biological mechanisms from harmful exposures and translate those discoveries into safer preventive therapies. An early-phase clinical trial is already exploring a carefully controlled, low-dose oral carbon monoxide intervention. As we work toward preventing Parkinson’s disease, we must remain curious enough to investigate unexpected findings, rigorous enough to challenge our assumptions, and cautious enough to distinguish promising biology from proven prevention. Sometimes the most important discoveries begin with a paradox. cutt.ly/2yOB2OkG

Post attachment
Linda avatar
⟳ Mark Hirsch retweeted
Linda@linda_ungureanu·Nov 9

Remembering the ones who always made us look up🤍✨ “Carl wanted us to see ourselves not as the failed clay of a disappointed Creator but as starstuff, made of atoms forged in the fiery hearts of distant stars. To him we were “starstuff pondering the stars; organized assemblages of 10 billion billion billion atoms considering the evolution of atoms; tracing the long journey by which, here at least, consciousness arose”. For him science was, in part, a kind of “informed worship”. No single step in the pursuit of enlightenment should ever be considered sacred, only the search was.” Preface by Ann Druyan to The varieties of scientific experience. A personal view of the search of God | Carl Sagan

Post attachmentPost attachment